[Breast-preserving treatment in patients with stage I and II breast carcinoma]

Very low local recurrence rates after breast-conserving therapy: analysis of 8485 patients treated over a 28-year period.

Breast cancer research and treatment·2016

Gene expression profiling to predict the risk of locoregional recurrence in breast cancer: a pooled analysis.

Breast cancer research and treatment·2014

Long-term cosmetic changes after breast-conserving treatment of patients with stage I-II breast cancer and included in the EORTC 'boost versus no boost' trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2012

Locoregional recurrence after breast-conserving therapy remains an independent prognostic factor even after an event free interval of 10 years in early stage breast cancer.

European journal of cancer (Oxford, England : 1990)·2012

Tailored follow-up for early breast cancer patients: a prognostic index that predicts locoregional recurrence.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2010